Patients with NSCLC with higher platelet ITGA2B mRNA expression levels had remarkably worse OS rate compared to patients with lower platelet ITGA2B (71.5% vs. 86.7%; p = 0.005), and CEA showed the similar result (88.1% vs. 66.0%; p < 0.001) whereas SELP not (77.4% vs 78.5%, p = 0.893), seen in Figure 7. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.